» Articles » PMID: 23392993

Risk of Thromboembolism in Shoulder Arthroplasty: Effect of Implant Type and Traumatic Indication

Overview
Publisher Wolters Kluwer
Specialty Orthopedics
Date 2013 Feb 9
PMID 23392993
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Prior research about symptomatic venous thromboembolism (VTE) after shoulder arthroplasty has not determined whether procedure type (hemiarthroplasty, total shoulder arthroplasty, or reverse shoulder arthroplasty) or surgical indication (traumatic or elective) represent risk factors for VTE after shoulder replacement.

Questions/purposes: We therefore asked whether the risk of symptomatic VTE events and mortality within 90 days of shoulder arthroplasty was influenced by (1) procedure type, and (2) surgical indication (traumatic or elective).

Methods: We performed a retrospective database review of symptomatic VTE events and mortality within 90 days of shoulder arthroplasty in a large (30-hospital) integrated healthcare system over a 5-year period, from January 2005 to December 2009. We compared the likelihood of VTE and death in patients undergoing reverse shoulder arthroplasties (RSAs), total shoulder arthroplasties (TSAs), and hemiarthroplasties (HAs), and we compared the likelihood of VTE and death in patients who underwent elective shoulder arthroplasties with those who underwent shoulder arthroplasty in the setting of acute trauma.

Results: In the 2574 eligible shoulder arthroplasties identified during the study period, VTE developed in 1.01% of patients (deep vein thrombosis 0.51% and pulmonary embolism 0.54%). With the numbers available, no differences were observed in rates of VTE or mortality by procedure type. A trend toward increased VTE occurred more frequently in patients having surgery for traumatic indications than after elective surgery (1.71% versus 0.80%; p = 0.055). A higher likelihood of 90-day mortality was observed in trauma patients compared with elective (odds ratio = 7.4; 95% CI, 2.4-25.2).

Conclusions: VTE occurred infrequently in this study sample. These data support future risk and benefit assessment of routine pharmacologic VTE prophylaxis in the perioperative treatment of patients undergoing shoulder arthroplasty, especially in all RSA and traumatic HA subsets, where the risk of VTE may be higher.

Citing Articles

Venous thromboembolism following surgical management of proximal humerus fractures: a systematic review.

Marigi E, Sperling Jr J, de Marinis R, Gupta P, Hassett L, Soza F JSES Rev Rep Tech. 2023; 3(4):494-498.

PMID: 37928990 PMC: 10624987. DOI: 10.1016/j.xrrt.2023.06.003.


Changes in Plasma Levels of ADAMTS13 and von Willebrand Factor in Patients Undergoing Elective Joint Arthroplasty.

He J, Schick S, Williams M, Wills B, Pinto M, Viner G J Clin Med. 2022; 11(21).

PMID: 36362664 PMC: 9655560. DOI: 10.3390/jcm11216436.


Impact of tranexamic acid on clinical and hematologic outcomes following total shoulder arthroplasty.

Kelly M, Turcotte J, Fowler M, West M, Lashgari C, Gelfand J Shoulder Elbow. 2022; 14(5):544-550.

PMID: 36199511 PMC: 9527491. DOI: 10.1177/17585732211023053.


Incidence, characteristics, and risk factors of venous thromboembolism in shoulder arthroplasty-a systematic review.

Na S, Kim D, Choi B, Cho C Int Orthop. 2022; 46(9):2081-2088.

PMID: 35761099 DOI: 10.1007/s00264-022-05496-w.


Risk Factors for Mortality and Readmission After Shoulder Hemiarthroplasty for Fracture.

Singh A, Schultzel M, Cafri G, Yian E, Dillon M, Navarro R J Shoulder Elb Arthroplast. 2021; 3:2471549219840441.

PMID: 34497948 PMC: 8282164. DOI: 10.1177/2471549219840441.


References
1.
Lyman S, Sherman S, Carter T, Bach P, Mandl L, Marx R . Prevalence and risk factors for symptomatic thromboembolic events after shoulder arthroplasty. Clin Orthop Relat Res. 2006; 448:152-6. DOI: 10.1097/01.blo.0000194679.87258.6e. View

2.
Jacobs J, Mont M, Bozic K, Della Valle C, Goodman S, Lewis C . American Academy of Orthopaedic Surgeons clinical practice guideline on: preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Bone Joint Surg Am. 2012; 94(8):746-7. PMC: 3326685. DOI: 10.2106/JBJS.9408.ebo746. View

3.
Saleem A, Markel D . Fatal pulmonary embolus after shoulder arthroplasty. J Arthroplasty. 2001; 16(3):400-3. DOI: 10.1054/arth.2001.20546. View

4.
Sperling J, Cofield R . Pulmonary embolism following shoulder arthroplasty. J Bone Joint Surg Am. 2002; 84(11):1939-41. DOI: 10.2106/00004623-200211000-00005. View

5.
Nagda S, Rogers K, Sestokas A, Getz C, Ramsey M, Glaser D . Neer Award 2005: Peripheral nerve function during shoulder arthroplasty using intraoperative nerve monitoring. J Shoulder Elbow Surg. 2007; 16(3 Suppl):S2-8. DOI: 10.1016/j.jse.2006.01.016. View